• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recent clinical trials of immunotherapy in non-small-cell lung cancer.

作者信息

Gkolfinopoulos Stavros, Mountzios Giannis

机构信息

Medical Oncology Department, BOC Oncology Center, Nicosia 2006, Cyprus.

2nd Medical Oncology Department, Henry Dunant Hospital Center, Athens 11526, Greece.

出版信息

Immunotherapy. 2019 Apr;11(6):461-466. doi: 10.2217/imt-2019-0021.

DOI:10.2217/imt-2019-0021
PMID:30860438
Abstract
摘要

相似文献

1
Recent clinical trials of immunotherapy in non-small-cell lung cancer.近期非小细胞肺癌免疫疗法的临床试验。
Immunotherapy. 2019 Apr;11(6):461-466. doi: 10.2217/imt-2019-0021.
2
Role of Immune Checkpoint Inhibitors in Small Cell Lung Cancer.免疫检查点抑制剂在小细胞肺癌中的作用。
Am J Ther. 2018 May/Jun;25(3):e349-e356. doi: 10.1097/MJT.0000000000000686.
3
Current uses of check inhibitors in the fight against advanced and/or metastatic lung cancer: will immunotherapy overcome chemotherapy?当前检查点抑制剂在治疗晚期和/或转移性肺癌中的应用：免疫疗法是否会超越化疗？
Curr Probl Cancer. 2019 Feb;43(1):43-53. doi: 10.1016/j.currproblcancer.2018.07.008. Epub 2018 Aug 4.
4
[The role of immune checkpoint inhibitors in lung cancer: from clinical trials to clinical practice].[免疫检查点抑制剂在肺癌中的作用：从临床试验到临床实践]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 12;43(2):95-99. doi: 10.3760/cma.j.issn.1001-0939.2020.02.006.
5
Non-small-cell lung cancer: what are the benefits and challenges of treating it with immune checkpoint inhibitors?非小细胞肺癌：用免疫检查点抑制剂治疗有何获益和挑战？
Immunotherapy. 2019 Sep;11(13):1149-1160. doi: 10.2217/imt-2019-0071. Epub 2019 Jul 30.
6
Immune Checkpoint Inhibitors in Lung Cancer and Melanoma.免疫检查点抑制剂在肺癌和黑色素瘤中的应用。
Semin Oncol Nurs. 2019 Oct;35(5):150932. doi: 10.1016/j.soncn.2019.08.011. Epub 2019 Sep 25.
7
The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.联合免疫疗法作为非小细胞肺癌一线治疗方法的应用。
Future Oncol. 2018 Feb;14(3):191-194. doi: 10.2217/fon-2017-0124. Epub 2018 Jan 16.
8
Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer.非小细胞肺癌免疫治疗的当前观点
Semin Oncol. 2015 Oct;42 Suppl 2:S11-8. doi: 10.1053/j.seminoncol.2015.09.019. Epub 2015 Sep 11.
9
Supportive care in the era of immunotherapies for advanced non-small-cell lung cancer.免疫治疗时代的晚期非小细胞肺癌的支持性治疗。
Curr Opin Oncol. 2018 Mar;30(2):98-104. doi: 10.1097/CCO.0000000000000434.
10
[Predictive biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer].[非小细胞肺癌中免疫检查点抑制剂的预测生物标志物]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 12;43(2):87-91. doi: 10.3760/cma.j.issn.1001-0939.2020.02.004.

引用本文的文献

1
The Role of Pentacyclic Triterpenoids in Non-Small Cell Lung Cancer: The Mechanisms of Action and Therapeutic Potential.五环三萜类化合物在非小细胞肺癌中的作用：作用机制与治疗潜力
Pharmaceutics. 2024 Dec 26;17(1):22. doi: 10.3390/pharmaceutics17010022.
2
The emerging nanomedicine-based technology for non-small cell lung cancer immunotherapy: how far are we from an effective treatment.新兴的基于纳米医学的非小细胞肺癌免疫治疗技术：我们距离有效治疗还有多远。
Front Oncol. 2023 Apr 27;13:1153319. doi: 10.3389/fonc.2023.1153319. eCollection 2023.
3
A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with mutation.
一种特殊的预后指标：肿瘤突变负荷与伴有突变的肺腺癌中免疫浸润情况相结合。
Transl Cancer Res. 2021 Sep;10(9):3963-3978. doi: 10.21037/tcr-21-565.
4
Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy.非小细胞肺癌中的纳米医学：从传统治疗到免疫疗法
Cancers (Basel). 2020 Jun 18;12(6):1609. doi: 10.3390/cancers12061609.
5
Current Perspectives in Cancer Immunotherapy.癌症免疫疗法的当前观点
Cancers (Basel). 2019 Sep 30;11(10):1472. doi: 10.3390/cancers11101472.